Charles River Laboratories | CRL - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Agilent USD 364M 78M 2025-12
Align Technology USD 148.89M 27.71M 2026-03
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cardinal Health USD 630M 32M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cigna USD 1.82B 478M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Elevance Health USD 2.16B 146M 2026-06
Humana USD 1.6B 2.61B 2026-03
Illumina USD 157M 220M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Intrexon USD -60.48M 27.09M 2024-06
IQVIA Holdings USD 6.22B 5.68B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Lonza CHF 624M 197M 2024-12
McKesson USD 1.63B 235M 2025-12
Merck EUR 401M 886.1M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Novartis USD 4.27B 430M 2026-06
Pfizer USD 5.18B 6.82B 2026-03
Quest Diagnostics USD 334M 4M 2026-03
Revvity USD 91.56M 35.88M 2025-12
Thermo Fisher Scientific USD 1.73B 389M 2026-03
United Therapeutics USD 444M 6M 2025-12
UnitedHealth USD 7.36B 600M 2026-06
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 264.18M 94.06M 2025-12
West Pharmaceutical Services USD 180.1M 18.6M 2026-03